Literature DB >> 23985680

Nuclear reprogramming and the cancer genome.

.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23985680     DOI： 10.1038/ng.2755

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  13 in total

1.  H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.

Authors:  Jiekai Chen; He Liu; Jing Liu; Jing Qi; Bei Wei; Jiaqi Yang; Hanquan Liang; You Chen; Jing Chen; Yaran Wu; Lin Guo; Jieying Zhu; Xiangjie Zhao; Tianran Peng; Yixin Zhang; Shen Chen; Xuejia Li; Dongwei Li; Tao Wang; Duanqing Pei
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330

2.  Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.

Authors:  Max Jan; Thomas M Snyder; M Ryan Corces-Zimmerman; Paresh Vyas; Irving L Weissman; Stephen R Quake; Ravindra Majeti
Journal:  Sci Transl Med       Date:  2012-08-29       Impact factor: 17.956

3.  Cancer: Resolving the stem-cell debate.

Authors:  Richard J Gilbertson; Trevor A Graham
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

4.  Generation of iPSCs from cultured human malignant cells.

Authors:  Jan E Carette; Jan Pruszak; Malini Varadarajan; Vincent A Blomen; Sumita Gokhale; Fernando D Camargo; Marius Wernig; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

5.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

Review 6.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

7.  Reprogramming of a melanoma genome by nuclear transplantation.

Authors:  Konrad Hochedlinger; Robert Blelloch; Cameron Brennan; Yasuhiro Yamada; Minjung Kim; Lynda Chin; Rudolf Jaenisch
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

Review 8.  Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host.

Authors:  Winston Timp; Andrew P Feinberg
Journal:  Nat Rev Cancer       Date:  2013-06-13       Impact factor: 60.716

Review 9.  Mechanisms of nuclear reprogramming by eggs and oocytes: a deterministic process?

Authors:  Jerome Jullien; Vincent Pasque; Richard P Halley-Stott; Kei Miyamoto; J B Gurdon
Journal:  Nat Rev Mol Cell Biol       Date:  2011-06-23       Impact factor: 94.444

10.  Subtypes of medulloblastoma have distinct developmental origins.

Authors:  Paul Gibson; Yiai Tong; Giles Robinson; Margaret C Thompson; D Spencer Currle; Christopher Eden; Tanya A Kranenburg; Twala Hogg; Helen Poppleton; Julie Martin; David Finkelstein; Stanley Pounds; Aaron Weiss; Zoltan Patay; Matthew Scoggins; Robert Ogg; Yanxin Pei; Zeng-Jie Yang; Sonja Brun; Youngsoo Lee; Frederique Zindy; Janet C Lindsey; Makoto M Taketo; Frederick A Boop; Robert A Sanford; Amar Gajjar; Steven C Clifford; Martine F Roussel; Peter J McKinnon; David H Gutmann; David W Ellison; Robert Wechsler-Reya; Richard J Gilbertson
Journal:  Nature       Date:  2010-12-08       Impact factor: 49.962
View more
  1 in total

1.  Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells.

Authors:  Subbroto Kumar Saha; Kyeongseok Kim; Gwang-Mo Yang; Hye Yeon Choi; Ssang-Goo Cho
Journal:  Int J Mol Sci       Date:  2018-05-09       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.